Januvia tablets contain the antihyperglycaemic medication, sitagliptin 50mg and are used to provide better control over blood sugar levels and reduce the risk of damage to blood vessels.
Type-2 diabetes is associated with increased risk of cardiovascular disease, blindness, kidney failure and stroke. The addition of Januvia to a diabetes management plan of dietary improvements and regular exercise helps to improve the health outcomes for diabetics who have a shorter life expectancy.
Sitagliptin helps to reduce blood sugar levels and lower the quantity of glucose released by the liver. Januvia helps to reduce vascular damage that can affect the organs of the body.